• Home
  • Contact Us!
  • Privacy Policy

Radio Metta

  • Home
  • Business
  • Education
  • Health
  • Home Deco
  • News
  • Real Estate
  • Technology
  • Contact Us!
  • Privacy Policy
Home» Health»EMA panel recommends nod for Pfizer’s breast cancer drug

EMA panel recommends nod for Pfizer’s breast cancer drug

Saheli 18 Sep 2016 Health Comments Off on EMA panel recommends nod for Pfizer’s breast cancer drug 474 Views

The Pfizer logo is seen at their world headquarters in New York April 28, 2014.  REUTERS/Andrew Kelly/File photo

U.S. drugmaker Pfizer Inc’s breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.

The Committee for Medicinal Products for Human Use (CHMP) gave a positive opinion for Ibrance to be used in combination with two existing therapies in women who have received prior endocrine therapy.

The CHMP’s opinion will now be reviewed by the EMA, Pfizer said in a statement on Friday.

Ibrance, approved by the U.S. Food and Drug Administration in February 2015, contributed about half a billion dollars of Pfizer’s total revenue of $13.1 billion in its latest quarter.

Novartis is also testing an experimental breast cancer pill which belongs to same drug class as Pfizer’s Ibrance. In May, tests on the drug were stopped early because of good results.

Pfizer’s shares were off slightly in premarket trading on Friday.

[Source:-Reuters]

breast cancer Drug EMA for nod panel Pfizer's recommends 2016-09-18
Tags breast cancer Drug EMA for nod panel Pfizer's recommends
Facebook Twitter Stumble linkedin Pinterest More

Authors

Posted by : Saheli
Previous Article :

Rajnath postpones visit to Russia, U.S.

Next Article :

Tents set on fire, troops shot while coming out

Related Articles

Clinical Trial Considerations for Infectious Disease Rapid Diagnostics: From Sample to Result in Record Time

Clinical Trial Considerations for Infectious Disease Rapid Diagnostics: From Sample to Result in Record Time

admin 04 Oct 2025
Digital Dermatology with Freedom 360: Skin Cancer Checks and Expert Care for Members

Digital Dermatology with Freedom 360: Skin Cancer Checks and Expert Care for Members

admin 15 Sep 2025
How is PSA used to monitor prostate cancer?

How is PSA used to monitor prostate cancer?

admin 01 Sep 2025

Latest Post

Clinical Trial Considerations for Infectious Disease Rapid Diagnostics: From Sample to Result in Record Time
Health

Clinical Trial Considerations for Infectious Disease Rapid Diagnostics: From Sample to Result in Record Time

admin 04 Oct 2025

Michael Kremer on the Andhra Pradesh PAL Study’s evidence of personalized adaptive learning in India

admin 22 Sep 2025
Digital Dermatology with Freedom 360: Skin Cancer Checks and Expert Care for Members
Health

Digital Dermatology with Freedom 360: Skin Cancer Checks and Expert Care for Members

admin 15 Sep 2025
Small, Rural Central California High School Continues To Defy Standardized Education
Education

Small, Rural Central California High School Continues To Defy Standardized Education

admin 12 Sep 2025
Speeches delivered by CEO Sundar Pichai at the White House AI Education Taskforce
Education

Speeches delivered by CEO Sundar Pichai at the White House AI Education Taskforce

admin 08 Sep 2025
How is PSA used to monitor prostate cancer?
Health

How is PSA used to monitor prostate cancer?

admin 01 Sep 2025
The Future of High Performance Networking: Ultra Ethernet Explained
Technology

The Future of High Performance Networking: Ultra Ethernet Explained

admin 28 Aug 2025
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
  • Home
  • Contact Us!
  • Privacy Policy
Copyright 2016, All Rights Reserved
Magazine Blog News WordPress Theme